Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Angiopoietins and diabetic nephropathy.

Gnudi L.

Diabetologia. 2016 May 20. [Epub ahead of print] Review.

PMID:
27207083
2.

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis.

Zheng S, Powell DW, Zheng F, Kantharidis P, Gnudi L.

J Diabetes Res. 2016;2016:5241549. doi: 10.1155/2016/5241549. Epub 2016 Jan 6. No abstract available.

3.

Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy.

Malik AN, Parsade CK, Ajaz S, Crosby-Nwaobi R, Gnudi L, Czajka A, Sivaprasad S.

Diabetes Res Clin Pract. 2015 Dec;110(3):257-65. doi: 10.1016/j.diabres.2015.10.006. Epub 2015 Oct 22.

PMID:
26625720
4.

Vascular growth factors play critical roles in kidney glomeruli.

Gnudi L, Benedetti S, Woolf AS, Long DA.

Clin Sci (Lond). 2015 Dec;129(12):1225-36. doi: 10.1042/CS20150403. Review.

PMID:
26561594
5.

Diabetic nephropathy: What does the future hold?

Montero RM, Covic A, Gnudi L, Goldsmith D.

Int Urol Nephrol. 2016 Jan;48(1):99-113. doi: 10.1007/s11255-015-1121-y. Epub 2015 Oct 5.

6.

A pilot study to evaluate the efficacy of class IV lasers on nonhealing neuroischemic diabetic foot ulcers in patients with type 2 diabetes.

Maltese G, Karalliedde J, Rapley H, Amor T, Lakhani A, Gnudi L.

Diabetes Care. 2015 Oct;38(10):e152-3. doi: 10.2337/dc15-0774. No abstract available.

PMID:
26404934
7.

Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy.

Czajka A, Ajaz S, Gnudi L, Parsade CK, Jones P, Reid F, Malik AN.

EBioMedicine. 2015 Apr 11;2(6):499-512. doi: 10.1016/j.ebiom.2015.04.002. eCollection 2015 Jun.

8.

Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents.

Gnudi L, Karalliedde J.

Nephrol Dial Transplant. 2015 Apr 8. pii: gfv093. [Epub ahead of print] Review.

9.

A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?

Gnudi L.

Nephrol Dial Transplant. 2015 Apr;30(4):525-7. doi: 10.1093/ndt/gfv053. No abstract available.

PMID:
25801635
10.

Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes.

Felice F, Di Stefano R, Pini S, Mazzotta G, Bovenzi FM, Bertoli D, Abelli M, Borelli L, Cardini A, Lari L, Gesi C, Michi P, Morrone D, Gnudi L, Balbarini A.

Hum Psychopharmacol. 2015 May;30(3):183-8. doi: 10.1002/hup.2470. Epub 2015 Mar 18.

PMID:
25784019
11.

Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease.

Karalliedde J, Gnudi L.

Nephrol Dial Transplant. 2016 Feb;31(2):206-13. doi: 10.1093/ndt/gfu405. Epub 2014 Dec 30. Review.

PMID:
25550448
12.

N-3 PUFA increase bioavailability and function of endothelial progenitor cells.

Spigoni V, Lombardi C, Cito M, Picconi A, Ridolfi V, Andreoli R, Anelli N, Gnudi L, Goldoni M, Zavaroni I, Raddino R, Dei Cas A.

Food Funct. 2014 Aug;5(8):1881-90. doi: 10.1039/c3fo60641d.

PMID:
24942553
13.

An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress.

Smillie SJ, King R, Kodji X, Outzen E, Pozsgai G, Fernandes E, Marshall N, de Winter P, Heads RJ, Dessapt-Baradez C, Gnudi L, Sams A, Shah AM, Siow RC, Brain SD.

Hypertension. 2014 May;63(5):1056-62. doi: 10.1161/HYPERTENSIONAHA.113.02517. Epub 2014 Feb 10.

14.

Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties.

Arnouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J, van Biesen W.

Nephrol Dial Transplant. 2014 Jul;29(7):1284-300. doi: 10.1093/ndt/gft462. Epub 2013 Dec 8. Review.

PMID:
24322578
15.

Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.

Dessapt-Baradez C, Woolf AS, White KE, Pan J, Huang JL, Hayward AA, Price KL, Kolatsi-Joannou M, Locatelli M, Diennet M, Webster Z, Smillie SJ, Nair V, Kretzler M, Cohen CD, Long DA, Gnudi L.

J Am Soc Nephrol. 2014 Jan;25(1):33-42. doi: 10.1681/ASN.2012121218. Epub 2013 Sep 5.

16.

Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.

Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1899-905. doi: 10.2215/CJN.02700313. Epub 2013 Aug 8.

17.

Albuminuria is associated with too few glomeruli and too much testosterone.

Long DA, Kolatsi-Joannou M, Price KL, Dessapt-Baradez C, Huang JL, Papakrivopoulou E, Hubank M, Korstanje R, Gnudi L, Woolf AS.

Kidney Int. 2013 Jun;83(6):1118-29. doi: 10.1038/ki.2013.45. Epub 2013 Feb 27.

18.

Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes.

Viswanathan V, Mohan V, Subramani P, Parthasarathy N, Subramaniyam G, Manoharan D, Sundaramoorthy C, Gnudi L, Karalliedde J, Viberti G.

Clin J Am Soc Nephrol. 2013 Feb;8(2):225-32. doi: 10.2215/CJN.06330612. Epub 2012 Nov 26.

19.

A role for TRPV1 in influencing the onset of cardiovascular disease in obesity.

Marshall NJ, Liang L, Bodkin J, Dessapt-Baradez C, Nandi M, Collot-Teixeira S, Smillie SJ, Lalgi K, Fernandes ES, Gnudi L, Brain SD.

Hypertension. 2013 Jan;61(1):246-52. doi: 10.1161/HYPERTENSIONAHA.112.201434. Epub 2012 Nov 12.

20.

Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.

Spigoni V, Picconi A, Cito M, Ridolfi V, Bonomini S, Casali C, Zavaroni I, Gnudi L, Metra M, Dei Cas A.

PLoS One. 2012;7(11):e48283. doi: 10.1371/journal.pone.0048283. Epub 2012 Nov 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk